Sentences with phrase «omics research»

Patient registries, biobanks and bioinformatics analysis tools are the key infrastructure tools required for omics research.

Not exact matches

«We have been able to produce a precise omics - level molecular atlas of the aortic valve and the molecular network of calcific aortic valve disease,» said first author Florian Schlotter, MD, a research fellow in the Center for Interdisciplinary Cardiovascular Sciences at BWH.

«We've embedded clinical researchers and facilities in academic hospitals, with close links to the research environment around them, including access to technology for «omics and imaging,» says Williams.

IOM found many potential problems inherent in tests based on omics, which it defines as research that looks for patterns in large sets of molecules such as proteins, DNA, RNA, or metabolites.

«There is a strong movement in systems biology to become more translational,» says Fabian Theis, director of the Institute of Computational Biology at the Helmholtz Zentrum München, in Germany, «and medical research is generating lots of «omics measurements.»

Starting with Genomics, the so - called «Omics Revolution» has resulted in the creation (or renaming) of a broad range of research areas, including proteomics, metabolomics, interferomics, and glycomics.

The goal of the center is to produce original high - impact research in the fields of translational - omics and bioinformatics, to enrich and enhance research occurring within other divisions and departments with these disciplines, as well as to foster novel collaborative projects across the Institute.

The Center for Translational Genomics and Bioinformatics strongly supports as well as initiates novel, interdisciplinary research that will project IRCCS Ospedale San Raffaele towards tackling disease through - omics driven translational approaches.

Systems biology is an approach to biomedical research in which scientists combine complex «omics» datasets to develop a more complete understanding of complex biological systems, such as the regulation of whole genome - level transcription, regulation of the 3D genome, the role of signaling and metabolic pathways in disease, and more.

From their site: «OMICtools strives to accelerate research in bioinformatics, making tools accessible to everyone and offering a stimulating work environment to assist life scientists extracting new findings from the omics data.»

The Omics in Space project is funded by NASA's Translational Research Institute for Space Health, which is jointly operated with the Baylor College of Medicine in Houston, Texas.

There is also a postdoc research associate position open in parasite genomics, as part of an established and successful research group focused on integrating «omics» approaches aimed at understanding organisms at a molecular level.

Funded as part of the EU's commitment to the International Rare Diseases Research Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools into a central research resource for rare dResearch Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools into a central research resource for rare dresearch resource for rare diseases.

The three linked projects funded by the European Commission as flagship «omics» research projects under the International Rare Diseases Research Consortium are now just over a yresearch projects under the International Rare Diseases Research Consortium are now just over a yResearch Consortium are now just over a year old.

Dr. Smoller is a Tepper Family MGH Research Scholar and also serves as Director of the Omics Unit of the MGH Division of Clinical Research and co-Director of the Partners HealthCare Biobank at MGH.

With the development of high - throughput technologies, such as Next Generation Sequencing (NGS), which allows to sequence entire genomes, the omics field is rapidly expanding and creating new perspectives for research and diagnosis.

Dr. Lanteri now serves as Director Scientific Affairs at Cerus Corporation while remaining an Affiliate Investigator at BSRI, participating in ongoing research with the REDS - III group of investigators on: i) Zika virus persistence using samples collected longitudinally from ZIKV - infected donors and ii) the red blood cell storage lesion through the RBC - Omics project.

It has been set up to address the problem of fragmentation in the rare disease research field, where individual efforts often have poor interoperability and do not systematically connect data across the levels of clinical phenotype, genetics and omics data, biomaterial availability and research / trial datasets.

(Now in charge at PNNL is Charles Ansong, a senior research scientist with the Integrative Omics group.)

Dr. Worthey received her Ph.D. in Genetics from the University of London in 2003 and completed her postdoctoral fellowship at the Seattle Biomedical Research Institute at the University of Washington, working on both Eukaryotic Genomics and other high throughput «Omics» projects.

Beall has written about OMICS» practices of using prominent people's names without permission, their charge of as much as $ 3,000 to publish one's research, and hosting sham conferences whose names are misleadingly close to real and prestigious events.

This is already happening, but if you look at things like PLOS, and the «omics journals, they are not held in high esteem by the academic world — I know this because at least one professor told us in class not to use them for our research.